Focalpoint Update: QbD joins at.las
At.las (Leveraging Affordable Solutions for Advanced Therapies) is a young ecosystem, relevant for all stakeholders involved with or passionate about advanced therapies (whether it are cell or gene therapies or tissue engineering). With ATMPs as one of our focal points, this is an ecosystem we can’t neglect!
At.las is clear on their website, saying:
Our ambition it to push innovation, to assist in bringing new products to the patients. How? By sharing experiences, spreading know-how and connecting the right people. Why? Because advanced therapies can help patients for whom there is no cure today.
The main purpose of our own ATMP-related product, Cell by Design®, is to make advanced therapies more affordable and therefore more accessible to everyone. As you can see, there’s a perfect fit between QbD and at.las.
And so we joined this interesting ecosystem as a member, together with many other members of the Belgian biotech-hub.
Curious where this partnership will take us!
You have any questions concerning ATMPs or Cell by Design®, contact us by clicking the button below!